Researchers Develop New Screening Method For Diabetes

March 23, 1998

Researchers at the University of Toronto have developed a more accurate method of detecting glucose intolerance, according to an article in the March issue of Diabetes Care.

Professor Thomas Wolever of the department of nutritional sciences and his team have created a standardized wafer of oats, soy and canola oil that can be used in testing for glucose intolerance. People with higher-than-normal blood glucose levels are 10 times more likely to develop diabetes than those with normal levels. Currently, the screening process for diabetes involves an overnight fast, followed by a blood sugar sample, a drink containing 75 grams of glucose and another blood sugar test two hours later.

"Our study found the standardized test meal does not produce the nausea often associated with the current glucose tolerance test and also provides more consistent results," says Wolever. "We think it's a major improvement over existing ways to screen for diabetes and impaired glucose tolerance."

Thirty-six people -- including those with normal and impaired glucose tolerance and mild diabetes -- participated in the study. Each subject had eight randomly allocated tests -- either the traditional glucose tolerance test or the standardized test wafer.

Diabetes is a major cause of blindness, kidney failure, heart disease and circulatory problems in the feet and legs. To prevent its onset, Wolever says, it's necessary to detect changes in blood sugar before signs of diabetes have begun to develop.

Screening is also helpful in detecting maturity onset diabetes, a form that takes years to develop and can exist for a long time in people without any symptoms. The researchers now plan to test their diabetes screening product on pregnant women.

Funding for the study was provided by Ceapro, a public company in Edmonton that produces oat products. A patent is pending. CONTACT: Professor Thomas Wolever, department of nutritional sciences, (416) 978-5556, e-mail: thomas.wolever@utoronto.ca, Carol Palmason, senior vice-president (pharmaceuticals), Ceapro, (403) 421-4555, e-mail: cpalmaso@ceapro.com or Christina Marshall, U of T public affairs, (416) 978-5949, e-mail: christina.marshall@utoronto.ca
-end-


University of Toronto

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.